The same trial in 2025 also noted a 5 kg reduction in visceral fat
5 Body composition effects of semaglutide and tirzepatide Long term use of semaglutide, tirzepatide and other potent medications in development, that produce robust weight loss, highlights the importance of the impact of weight loss on body composition, especially in older individuals
Confocal images of representative images of ICAM-1 expression on blood vessels in the parietal cortex and hippocampus CA1 region
When physicians were requested to indicate the reason behind initiating oral semaglutide for each patient, the most prevalent reasons were enhancing metabolic control (80.3%), reducing cardiovascular risk (82.9%), weight management (63.9%), lowering microvascular risk (29.3%), and mitigating the risk of hypoglycemia (14.5%)
According to Reuters, the U.S